PharmiWeb.com - Global Pharma News & Resources

Clinical trials - Press Releases

Date Title Company
19-Jun-2020 Sanofi announces positive long-term efficacy and safety data for fitusiran from interim analysis of Phase 2 extension study in people with hemophilia A and B, with or without inhibitors Sanofi
19-Jun-2020 Dupixent® (dupilumab) approved in China for adults with moderate-to-severe atopic dermatitis Sanofi
19-Jun-2020 Tiziana Granted First-Ever Patent on a Transformational Technology for Oral Delivery of all Anti-CD3 Monoclonal Antibodies for Treatment of Human Diseases Tiziana Life Sciences
19-Jun-2020 AACR Annual Meeting: Sermonix to present poster on lasofoxifene, CDK 4/6 combination Sermonix Pharmaceuticals
19-Jun-2020 RedHill Biopharma Expands Opaganib COVID-19 Phase 2/3 Study with Clinical Trial Applications in Italy and UK RedHill Biopharma
19-Jun-2020 PTC Therapeutics Announces the Initiation of a Phase 2/3 Clinical Trial to Evaluate PTC299 for the Treatment of COVID-19 PTC Therapeutics, Inc
19-Jun-2020 RINVOQ™ (upadacitinib) Monotherapy Shows Improvement in Skin Clearance and Itch in First Phase 3 Study for Atopic Dermatitis AbbVie
19-Jun-2020 Crown Bioscience Hosts Innovative Virtual AACR 2020 Conference and Tradeshow Crown Bioscience Inc
19-Jun-2020 PureTech Founded Entity Gelesis Announces Partnership for Commercial Launch of Plenity® in China PureTech Health plc
19-Jun-2020 Livinguard next-generation self-disinfecting technology proven effective in destroying the new coronavirus Livinguard AG
19-Jun-2020 Max Planck researchers feed Proteome AI with PharmaFluidics technology PharmaFluidics
19-Jun-2020 National expansion of Synairgen’s home-based COVID-19 trial of inhaled SNG001 Synairgen plc
19-Jun-2020 Chi-Med Announces Fruquintinib Granted U.S. FDA Fast Track Designation for Metastatic Colorectal Cancer Chi-Med
19-Jun-2020 Cancer’s reliance on fat could be targeted with new ‘drugs and diet’ treatment The Institute of Cancer Research
17-Jun-2020 Increasing number of hydroxychloroquine clinical trials for COVID-19 treatment will be withdrawn or terminated, says GlobalData GlobalData
17-Jun-2020 Switching to Ozempic® from another GLP-1 RA significantly reduced blood sugar and weight in people with type 2 diabetes in routine clinical practice Novo Nordisk
17-Jun-2020 Faron receives €2.1 million funding from Business Finland for Traumakine manufacturing Faron Pharmaceuticals Ltd
17-Jun-2020 Kyowa Kirin makes POTELIGEO® (mogamulizumab) available in Europe for the Treatment of Mycosis Fungoides and Sézary Syndrome, Two Rare Forms of Non-Hodgkin’s Lymphoma with High Unmet Medical Need Kyowa Kirin
17-Jun-2020 New Phase II data indicate regimen of Truxima® (biosimilar rituximab), lenalidomide and acalabrutinib (R2A) may be well tolerated and effective in relapsed/refractory aggressive B-cell lymphoma Celltrion Healthcare
17-Jun-2020 Wipro launches Digital Inspection Solution powered by IBM® TRIRIGA® Wipro Limited